Lipodystrophy syndromeassociated with insulin resistance plays a role in the development of fatty liver disease.By enhancing insulin sensitivity, PPARγ agonists or thiazolinediones are used for thetreatment of type 2 diabetes. Here, PPARG is linked to fatty liver disease.